Korea United Pharm Inc.
Research Korea United Pharm Inc. (033270.KS) on Bullrun: market cap KRW 281.37B, dividend yield 3.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker033270.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 281.37B
- Dividend yield3.9%
- Financial periodQ2 2026
- RevenueKRW 77.22B
- Net incomeKRW 37.71B
- Free cash flowKRW 12.23B
- Gross margin55.5%
Valuation Snapshot
latest market cap is KRW 281.37B; dividend yield is 3.9%.
Peer valuation comparison
Latest dividend yield is 3.89% versus a Healthcare sector median of 2.4% (62.1% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 281.37B | n/a | 3.4% | 610 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 610 KRW, yield 3.9%.
About Korea United Pharm Inc.
Korea United Pharm Inc. engages in the manufacture and sale of pharmaceutical products in South Korea. It offers products in the areas of respiratory system, musculo-skeletal system, gastro-intestinal tract system, cardiovascular system, anti-cancer, anti-infectives, allergy, immune system, central nervous system, and other diseases, as well OTC drugs. The company also exports its products to approximately 40 countries. Korea United Pharm Inc. was founded in 1987 and is headquartered in Seoul, South Korea.
ETFs that hold Korea United Pharm Inc.
US-listed ETFs
Korea United Pharm Inc. is held by 15 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Vanguard FTSE Developed Markets Index Fund ETF Shares (VEA) | <0.01% | 0.03% |
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| Avantis Emerging Markets Equity ETF (AVEM) | <0.01% | 0.33% |
| Vanguard FTSE Pacific Index Fund ETF Shares (VPL) | <0.01% | 0.07% |
| Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS) | <0.01% | 0.06% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Korea United Pharm Inc.'s market cap?
Korea United Pharm Inc.'s market capitalization is KRW 281.37B.
Does Korea United Pharm Inc. pay a dividend?
Korea United Pharm Inc. has a dividend yield of 3.9%.
What does Korea United Pharm Inc. do?
Korea United Pharm Inc. engages in the manufacture and sale of pharmaceutical products in South Korea. It offers products in the areas of respiratory system, musculo-skeletal system, gastro-intestinal tract system, cardiovascular system, anti-cancer, anti-infectives, allergy, immune system, central nervous system, and other diseases, as well OTC drugs. The company also exports its products to approximately 40 countries. Korea United Pharm Inc. was founded in 1987 and is headquartered in Seoul, South Korea.